A ‘super-premium' chicken concept is expanding into Salt Lake City
Starbird, a 'super-premium' fast food concept, announced on Monday it would be opening five locations in the Salt Lake City area, with the first openings expected in late 2025 and early 2026. The California-based restaurant said Salt Lake City was chosen for its thriving food scene and demand for modern dining options.
It is currently unclear where exactly in the Salt Lake Valley the Starbird locations would be.
The fast-food chain is known for its , including salads, bowls, wings, and breakfast options. Starbird also boasts its nine house-made dipping sauces and its unique proprietary recipe of gluten-free flours and spices for its chicken.
Dutch Bros has a new menu item that's only available in Utah (and one other state)
In addition to the five locations in Salt Lake City, Starbird also announced five restaurants in Chicago, Illinois.
'As we continue expanding into new markets, we're looking forward to collaborating with operators who share our passion for unmatched food and operational excellence,' said Starbird Founder and CEO Aaron Noveshen. 'Their experience and dedication will be instrumental in successfully bringing Starbird to these regions.'
Noveshen did not say who would be operating the Salt Lake City-based franchises, only saying they bring decades of experience of operating successful restaurant brands.
Along with the new Salt Lake City and Chicago locations, Starbird recently announced new locations in Denver, Colorado. The chain said it also has franchise opportunities in Oregon, Washington, Nevada, Arizona, Texas, Illinois and Florida.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Philippe Laffont's Strategic Moves: Oracle Corp Takes Center Stage with 2.35% Portfolio Allocation
Insightful Analysis of Philippe Laffont (Trades, Portfolio)'s Latest 13F Filing Warning! GuruFocus has detected 5 Warning Signs with CRWV. Philippe Laffont (Trades, Portfolio), a prominent figure in the investment world, recently submitted his 13F filing for the second quarter of 2025, revealing strategic adjustments in his portfolio. Laffont is the founder of Coatue Management, a hedge fund known for its tech-centric investment approach. Established in 1999, Coatue Management operates from its headquarters in New York, with additional offices in Edison, New Jersey, and Menlo Park, California. The firm employs a fundamental analysis strategy, focusing on both long and short positions, and is renowned for its top-down stock-picking methodology. Coatue primarily invests in publicly traded equity securities, with a significant emphasis on the information technology sector, which constitutes over half of its total assets. The firm also diversifies its investments across consumer discretionary, healthcare, utilities, telecommunications, and energy sectors. Summary of New Buy Philippe Laffont (Trades, Portfolio) added a total of 13 stocks to his portfolio this quarter. The most significant addition was Oracle Corp (NYSE:ORCL), with 3,857,262 shares, accounting for 2.35% of the portfolio and a total value of $843.31 million. The second largest addition was ARM Holdings PLC (NASDAQ:ARM), consisting of 4,633,454 shares, representing approximately 2.09% of the portfolio, with a total value of $749.41 million. The third largest addition was Chime Financial Inc (NASDAQ:CHYM), with 10,821,992 shares, accounting for 1.04% of the portfolio and a total value of $373.47 million. Key Position Increases Philippe Laffont (Trades, Portfolio) also increased stakes in a total of 19 stocks. The most notable increase was in Broadcom Inc (NASDAQ:AVGO), with an additional 2,075,267 shares, bringing the total to 5,647,507 shares. This adjustment represents a significant 58.09% increase in share count, a 1.59% impact on the current portfolio, and a total value of $1,556.74 million. The second largest increase was in CoreWeave Inc (NASDAQ:CRWV), with an additional 3,394,574 shares, bringing the total to 17,797,573. This adjustment represents a significant 23.57% increase in share count, with a total value of $2,902.07 million. Summary of Sold Out Philippe Laffont (Trades, Portfolio) completely exited 13 holdings in the second quarter of 2025. Notable exits include Super Micro Computer Inc (NASDAQ:SMCI), where Laffont sold all 8,866,735 shares, resulting in a -1.34% impact on the portfolio. Another significant exit was Monolithic Power Systems Inc (NASDAQ:MPWR), with the liquidation of all 193,432 shares, causing a -0.49% impact on the portfolio. Key Position Reduces Philippe Laffont (Trades, Portfolio) also reduced positions in 19 stocks. The most significant changes include a reduction in Alibaba Group Holding Ltd (NYSE:BABA) by 2,933,936 shares, resulting in a -77.17% decrease in shares and a -1.71% impact on the portfolio. The stock traded at an average price of $118.61 during the quarter and has returned 0.13% over the past 3 months and 46.32% year-to-date. Another notable reduction was in Atlassian Corp (NASDAQ:TEAM) by 962,199 shares, resulting in a -29.42% reduction in shares and a -0.9% impact on the portfolio. The stock traded at an average price of $208.3 during the quarter and has returned -24.59% over the past 3 months and -31.56% year-to-date. Portfolio Overview As of the second quarter of 2025, Philippe Laffont (Trades, Portfolio)'s portfolio included 70 stocks. The top holdings were 8.08% in CoreWeave Inc (NASDAQ:CRWV), 7.57% in Meta Platforms Inc (NASDAQ:META), 6.21% in Inc (NASDAQ:AMZN), 5.54% in GE Vernova Inc (NYSE:GEV), and 5.45% in Microsoft Corp (NASDAQ:MSFT). The holdings are mainly concentrated in 9 of the 11 industries: Technology, Communication Services, Consumer Cyclical, Industrials, Financial Services, Utilities, Healthcare, Consumer Defensive, and Real Estate. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus. Melden Sie sich an, um Ihr Portfolio aufzurufen.
Associated Press
27 minutes ago
- Associated Press
Centene Corporation (CNC) Faces Shareholder Ire Amidst Plummeting Stock and Lawsuit Over 'Inflated Guidance'
SAN FRANCISCO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Before the markets opened on July 25, 2025, investors in Centene Corporation (NYSE: CNC) saw the price of their shares decline about 10% in pre-market trading after the company reported disastrous Q2 2025 financial results. The company, a prominent provider of government-sponsored and commercial healthcare services, finds itself embroiled in a class action lawsuit following a dramatic plunge in its stock price. The suit, Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.), seeks to represent investors who purchased or acquired Centene securities between December 12, 2024, and June 30, 2025, alleging violations of the Securities Exchange Act of 1934. National shareholders rights firm Hagens Berman continues to investigate the securities law claims and urges Centene investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys. Class Period: Dec. 12, 2024 – June 30, 2025 Lead Plaintiff Deadline: Sept. 8, 2025 Visit: Contact the Firm Now: [email protected] 844-916-0895 Centene Q2 2025 Financial Results On July 25, 2025, Centene reported a GAAP diluted loss per share of -$0.51 'driven primarily by a reduction in the Company's net 2025 Marketplace risk adjustment revenue transfer estimate.' The Centene Securities Class Action Centene Corporation and its top executives are facing a class-action lawsuit accusing them of portraying an overly optimistic view of the company's financial health and future prospects, misleading investors about its enrollment and market conditions. According to the complaint, during the alleged Class Period, Centene's leadership gave the impression that it had solid, reliable information about projected revenue growth while touting strong enrollment rates and low morbidity levels among its members. For months, Centene's public statements painted a picture of expanding market share and a robust business, particularly focused on serving underinsured and uninsured populations. Yet, the lawsuit alleges that these upbeat reports were disconnected from reality. A preliminary analysis covering more than two-thirds of Centene's Marketplace share reportedly showed lower-than-expected enrollment alongside higher aggregate morbidity rates. This disparity between official statements and internal data forms the core grievance of shareholders. The situation reached a critical point on July 1, 2025, when Centene abruptly withdrew its 2025 financial guidance. The company cited a thorough review of Marketplace data from independent actuarial firm Wakely, revealing that market growth across Centene's 22 Health Insurance Marketplace states was 'lower than expected,' with morbidity levels significantly exceeding and 'materially inconsistent with' the company's earlier assumptions for risk adjustment revenue transfer used in its 2025 guidance. This unexpected revision led to the elimination of Centene's guidance, sending its stock tumbling more than 40 percent and wiping out billions in shareholder value overnight. The lawsuit contends that investors were misled by a narrative of sustained growth and healthy enrollment that, in truth, did not reflect the company's operational realities. 'The allegations, if proven true, suggest a pattern of where Centene's public optimism didn't align with the internal metrics, ultimately leaving investors holding the bag,' stated Reed Kathrein, a partner at Hagens Berman. If you invested in Centene and have substantial losses, or have knowledge that may assist the firm's investigation, submit your losses now » If you'd like more information and answers to frequently asked questions about the Centene investigation, read more» Whistleblowers: Persons with non-public information regarding Centene should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected]. About Hagens Berman Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at Follow the firm for updates and news at @ClassActionLaw. Contact: Reed Kathrein, 844-916-0895
Washington Post
27 minutes ago
- Washington Post
Trader Joe's wines are sneaky good. Here are 9 budget bottles to try.
During a recent trip to buy wine at Trader Joe's, the cashier did a double take when he read my total. 'Wow, that's a whole lot of wine for $200,' he said, laughing. He wasn't wrong. On average, each wine in my 23-bottle haul cost less than $8.50, a low figure from every side of the register. Even in TJ's terms, it's a bargain: Over in the baking aisle, a 4-ounce bottle of Trader Joe's organic vanilla extract is $9.99.
